MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Drug Delivery (Transdermal Patches_Microneedles)
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
Organization & Developments: Zynerba
Parents
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
Children
2017: Zynerba Pharmaceuticals Could Run Up Due To Upcoming Key Catalysts: Our Idea Of The Month - Zynerba Pharmaceuticals (NASDAQ:ZYNE)
2018: Zynerba Pharmaceuticals: Key Readouts In 2019_seekingalpha.com
2018: Zynerba: The Investment Case Still Holds_seekingalpha.com
2018: Zynerba: Transdermal Cannabinoids Have Significant Potential - Zynerba Pharmaceuticals (NASDAQ:ZYNE)
2018: Zynerba's FDA Meeting Lands It One Step Closer To FDA Approval - Zynerba Pharmaceuticals (NASDAQ:ZYNE)
2020: Revisiting Zynerba Pharmaceuticals_seekingalpha.com
2020: Rockwell Medical (RMTI)_3 “Strong Buy” Healthcare Stocks With Triple-Digit Upside
2020: Zynerba flunks another major trial, all but ending Fragile X hopes – Endpoints News
A clinical-stage pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments
Jumps
*Key People: Zynerba
Finance & Acquisitions: Zynerba